Emergency use of Cisapride for infant feeding intolerance.,
Role: PI,
Status: Completed
Federal
Pain and hypoxia in premature neonates,
Role: Investigator,
National Institutes of Health/DHHS,
(06/2024 - 06/2025)
Status: Approved
Systemic Hypotension following pediatric surgical procedures including patent ductus arteriosus ligation: the role of adrenal immaturity,
Role: Investigator,
National Heart, Lung, and Blood Institute/NIH/DHHS,
(02/2012 - 02/2013)
Status: Completed
Pain and Hypoxia in Premature Neonates,
Role: Consultant,
National Institute of Nursing Research/NIH/DHHS,
(07/2009 - 04/2014)
Status: Closed
Pharmacokinetics of L-arginine in premature infants,
Role: Co-investigator,
National Medical Technology Testbed, Inc.,
(02/2009 - 03/2011)
Status: Closed
Procedural pain and hypoxia in preterm infants (R21),
Role: Co-investigator,
National Institutes of Health/DHHS,
(07/2007 - 05/2008)
Status: Closed
For Profit Organization
An open label, multicenter, phase 2, pilot evaluation of surfaxin (lucinactant) delivered as an aerosol via nasal continuous positive airway pressure (NCPAP) in the prevention of respiratory distress syndrome in premature infants,
Role: Investigator,
Discovery Laboratories, Inc.,
(01/2006 - 01/2007)
Status: Completed
KL4-BPD-01 A randomized, double-blind, placebo-controlled trials to assess the safety and efficacy of surfaxin® (lucinactant), in very low birth weight (VLBW) infants at risk for developing bronchopulmonary dysplasia. IND # 40,287,
Role: Investigator,
Discovery Laboratories, Inc.,
(08/2005 - 08/2006)
Status: Completed
A phase III randomized, double-blind, multi-center clinical trial comparing the safety and efficacy of Veronate versus placebo for the prevention of nosocomial staphylococcal sepsis in premature infants (birth weight 500-1250gm),
Role: Investigator,
Inhibitex, Inc.,
(07/2005 - 07/2006)
Status: Completed
A pivotal phase III study of MEDI-493, a humanized respiratory syncytial virus monoclonal antibody, for the prophylaxis of severe RSV disease in premature infants and infants with bronchopulmonary dysplasia,
Role: Investigator,
MedImmune, Inc.,
(10/1996 - 10/1997)
Status: Completed
Multicenter phase II study to assess the safety and preliminary efficacy of multiple doses of INH-A21, a donor selected human Staphylococcal Immune Globulin, in very low birth weight infants,
Role: Investigator,
Inhibitex, Inc.,
Status: Completed
Internal
Non-pharmacological interventions for procedural pain in premature neonates,
Role: Investigator,
LLU Basic Science,
(06/2024 - 06/2025)
Status: Approved
Comparison of standard educational neonatal resusitation program and use of etimulation educational program combined with neonatal resuscitation program: which method produces better results?,
Role: Investigator,
LLU School of Nursing,
(09/2008)
Status: Completed
Continous glucose measurement using the GlucoWatch G2 biographer in infants of diabetic mothers,
Role: Investigator,
LLU Dept. of Pediatrics,
(10/2005 - 10/2006)
Status: Completed
Supporting Parents of Premature Infants in the NICU,
Role: PI,
LLU Dept. of Pediatrics,
(08/1995 - 08/1996)
Status: Completed
Non-Profit Organization
A randomized, double blind, parallel-group, placebo controlled study to evaluate the efficacy and safety of IBP-9414 in premature infants 500-1500g birth weight in the prevention of Necrotizing Enterocolitis - The connection study,
Role: Investigator,
Infant Bacterial Therapeutics AB,
(04/2024 - 10/2024)
Status: Completed
Postnatal Growth and Retinopathy of Prematurity Model Development Study (G-ROP-1),
Role: Research Assistant,
Children's Hospital Philadelphia,
(09/2012 - 03/2019)
Status: Closed